The von Hippel-Lindau (VHL) is a putative tumor suppressor gene which has been proposed to exert inhibitory effects on angiogenesis and tumor cell migration, through negative regulation of HIF1 and the stromal-derived factor-1 (SDF-1) receptor, CXCR4. The gene discussed is CXCR4; the disease is neoplasm.